Literature DB >> 19741091

Differentiation of larva migrans caused by Baylisascaris procyonis and Toxocara species by Western blotting.

Sriveny Dangoudoubiyam1, Kevin R Kazacos.   

Abstract

Baylisascaris procyonis and Toxocara species are two important causes of larva migrans in humans. Larva migrans caused by Toxocara spp. is well known and is diagnosed serologically by enzyme immunoassay. Over a dozen cases of larva migrans and associated eosinophilic encephalitis caused by B. procyonis have also been reported, and at least a dozen additional cases are known. An enzyme-linked immunosorbent assay (ELISA) using the excretory-secretory (ES) antigen of B. procyonis larvae is currently being used in our laboratory as an aid in the diagnosis of this infection in humans. Clinically affected individuals show very high reactivity (measured as the optical density) on this ELISA; however, a one-way cross-reactivity with Toxocara spp. has been observed. As an approach to differentiate these two infections based on serology, we performed Western blots, wherein the B. procyonis ES antigen was reacted with serum samples from individuals known to be positive for either Toxocara spp. or B. procyonis larva migrans. Western blot results showed that B. procyonis antigens of between 30 and 45 kDa were specifically identified only by the sera from individuals with Baylisascaris larva migrans, thus allowing for differentiation between the two infections. This included human patient serum samples submitted for serologic testing, as well as sera from rabbits experimentally infected with B. procyonis. When used in conjunction with the ELISA, Western blotting could be an efficient tool for diagnosis of this infection in humans.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19741091      PMCID: PMC2772376          DOI: 10.1128/CVI.00251-09

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  23 in total

1.  Comparative analysis of larval excretory-secretory antigens of Baylisascaris procyonis, Toxocara canis and Ascaris suum by Western blotting and enzyme immunoassay.

Authors:  W M Boyce; B A Branstetter; K R Kazacos
Journal:  Int J Parasitol       Date:  1988-02       Impact factor: 3.981

Review 2.  Highlights of human toxocariasis.

Authors:  J F Magnaval; L T Glickman; P Dorchies; B Morassin
Journal:  Korean J Parasitol       Date:  2001-03       Impact factor: 1.341

3.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

4.  The nature of visceral larva migrans.

Authors:  P C Beaver
Journal:  J Parasitol       Date:  1969-02       Impact factor: 1.276

5.  Eosinophil-associated inflammation and elaboration of eosinophil-derived proteins in 2 children with raccoon roundworm (Baylisascaris procyonis) encephalitis.

Authors:  C L Moertel; K R Kazacos; J H Butterfield; H Kita; J Watterson; G J Gleich
Journal:  Pediatrics       Date:  2001-11       Impact factor: 7.124

Review 6.  Baylisascariasis.

Authors:  Patrick J Gavin; Kevin R Kazacos; Stanford T Shulman
Journal:  Clin Microbiol Rev       Date:  2005-10       Impact factor: 26.132

7.  Case 4. The first fatal Baylisascaris infection in humans: an infant with eosinophilic meningoencephalitis.

Authors:  D S Huff; R C Neafie; M J Binder; G A De León; L W Brown; K R Kazacos
Journal:  Pediatr Pathol       Date:  1984

Review 8.  Toxocariasis: clinical aspects, epidemiology, medical ecology, and molecular aspects.

Authors:  Dickson Despommier
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

9.  Full recovery from Baylisascaris procyonis eosinophilic meningitis.

Authors:  Poulomi J Pai; Brian G Blackburn; Kevin R Kazacos; Rajasekharan P Warrier; Rodolfo E Bégué
Journal:  Emerg Infect Dis       Date:  2007-06       Impact factor: 6.883

10.  Raccoon roundworm eggs near homes and risk for larva migrans disease, California communities.

Authors:  Gabriel P Roussere; William J Murray; Caroline B Raudenbush; Michael J Kutilek; Darcy J Levee; Kevin R Kazacos
Journal:  Emerg Infect Dis       Date:  2003-12       Impact factor: 6.883

View more
  10 in total

1.  Molecular cloning of an immunogenic protein of Baylisascaris procyonis and expression in Escherichia coli for use in developing improved serodiagnostic assays.

Authors:  Sriveny Dangoudoubiyam; Ramesh Vemulapalli; Kathy Hancock; Kevin R Kazacos
Journal:  Clin Vaccine Immunol       Date:  2010-10-06

2.  Recombinant antigen-based enzyme-linked immunosorbent assay for diagnosis of Baylisascaris procyonis larva migrans.

Authors:  Sriveny Dangoudoubiyam; Ramesh Vemulapalli; Momar Ndao; Kevin R Kazacos
Journal:  Clin Vaccine Immunol       Date:  2011-08-10

3.  Baylisascaris Procyonis Neural Larva Migrans in an Infant in New York City.

Authors:  Jason E Perlman; Kevin R Kazacos; Gavin H Imperato; Rajen U Desai; Susan K Schulman; Jon Edwards; Lucy R Pontrelli; Fabiana S Machado; Herbert B Tanowitz; Norman A Saffra
Journal:  J Neuroparasitology       Date:  2010

Review 4.  Update on Baylisascariasis, a Highly Pathogenic Zoonotic Infection.

Authors:  Carlos Graeff-Teixeira; Alessandra Loureiro Morassutti; Kevin R Kazacos
Journal:  Clin Microbiol Rev       Date:  2016-04       Impact factor: 26.132

5.  Interlaboratory optimization and evaluation of a serological assay for diagnosis of human baylisascariasis.

Authors:  Lisa N Rascoe; Cynthia Santamaria; Sukwan Handali; Sriveny Dangoudoubiyam; Kevin R Kazacos; Patricia P Wilkins; Momar Ndao
Journal:  Clin Vaccine Immunol       Date:  2013-09-18

6.  Evaluation of the initial and chronic phases of toxocariasis after consumption of liver treated by freezing or cooling.

Authors:  Gisele Ferreira Dutra; Nitza Souto França Pinto; Luciana Farias da Costa de Avila; Paula de Lima Telmo; Vanusa Pousada da Hora; Lourdes Helena Rodrigues Martins; Maria Elisabeth Aires Berne; Carlos James Scaini
Journal:  Parasitol Res       Date:  2013-03-15       Impact factor: 2.289

7.  In vitro culture of Parascaris equorum larvae and initial investigation of parasite excretory-secretory products.

Authors:  Steffanie V Burk; Sriveny Dangoudoubiyam; Tammy Brewster-Barnes; Uneeda K Bryant; Daniel K Howe; Craig N Carter; Eric S Vanzant; Robert J Harmon; Kevin R Kazacos; Mary G Rossano
Journal:  Parasitol Res       Date:  2014-09-11       Impact factor: 2.289

8.  Molecular analysis of Baylisascaris columnaris revealed mitochondrial and nuclear polymorphisms.

Authors:  Frits Franssen; Kayin Xie; Hein Sprong; Joke van der Giessen
Journal:  Parasit Vectors       Date:  2013-04-29       Impact factor: 3.876

9.  Possible pet-associated baylisascariasis in child, Canada.

Authors:  Shariq Haider; Krishna Khairnar; Donald S Martin; James Yang; Filip Ralevski; Kevin R Kazacos; Dylan R Pillai
Journal:  Emerg Infect Dis       Date:  2012-02       Impact factor: 6.883

10.  Baylisascaris procyonis Parasites in Raccoons, Costa Rica, 2014.

Authors:  Mario Baldi; Gilbert Alvarado; Steve Smith; Mario Santoro; Natalie Bolaños; Carlos Jiménez; Sabine E Hutter; Chris Walzer
Journal:  Emerg Infect Dis       Date:  2016-08       Impact factor: 6.883

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.